Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors

NCT05547906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: ASCA101

Sponsor

MetaFines